Suchergebnisse - (Person:"Liang, Tingbo")

PubPharm (10)

1

In Situ Formed ROS-Responsive Hydrogel with STING Agonist and Gemcitabine to Intensify Immunotherapy against Pancreatic Ductal Adenocarcinoma

enthalten in: Advanced healthcare materials | 2023

von Wang, M. | Hu, Q. | Huang, J. | +5

2

Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01) : a multicentre, single-arm, phase 2b study

enthalten in: The Lancet. Oncology | 2023

von Harding, J. | Fan, J. | Oh, D. | +61

3

A tumor microenvironment-stimuli responsive nano-prodrug for overcoming gemcitabine chemoresistance by co-delivered miRNA-21 modulator

enthalten in: Biomedical materials (Bristol, England) | 2023

von Zhang, F. | Yao, Z. | Jin, P. | +5

4

A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors

enthalten in: Journal of controlled release : official journal of the Controlled Release Society | 2023

von Zhang, F. | Hu, Q. | Li, B. | +7

5

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer : a prospective, randomized, open-label, single center trial

enthalten in: BMC cancer | 2022

von Ma, T. | Bai, X. | Wei, Q. | +10

6

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial

enthalten in: BMC cancer | 2022

von Ma, T. | Bai, X. | Wei, Q. | +10

7

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial

enthalten in: BMC cancer | 2022

von Ma, T. | Bai, X. | Wei, Q. | +10

8

Tumour cell-derived debris and IgG synergistically promote metastasis of pancreatic cancer by inducing inflammation via tumour-associated macrophages

enthalten in: British journal of cancer | 2019

von Chen, Q. | Wang, J. | Zhang, Q. | +12

9

USP9X inhibition improves gemcitabine sensitivity in pancreatic cancer by inhibiting autophagy

enthalten in: Cancer letters | 2018

von Ma, T. | Chen, W. | Zhi, X. | +10

10

OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo

enthalten in: Oncotarget | 2015

von Zhi, X. | Chen, W. | Xue, F. | +8

1
[1]